| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-4274(98)00297-5 |
| P698 | PubMed publication ID | 10022244 |
| P2093 | author name string | Krammer PH | |
| P2860 | cites work | Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule | Q24305174 |
| A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain | Q24306835 | ||
| FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis | Q24307362 | ||
| RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death | Q24307376 | ||
| Human Fas ligand: gene structure, chromosomal location and species specificity | Q24310150 | ||
| Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death | Q24311298 | ||
| Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation | Q27732032 | ||
| The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19 | Q28188657 | ||
| Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family | Q28285445 | ||
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand | Q28513283 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| The Fas death factor | Q29620461 | ||
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity | Q33980970 | ||
| Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover | Q36236704 | ||
| Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. | Q36365423 | ||
| The role of APO-1-mediated apoptosis in the immune system | Q36677969 | ||
| Regulation of apoptosis in the immune system | Q36732039 | ||
| Fas-mediated cytotoxicity--a new immunoregulatory and pathogenic function of Th1 CD4+ T cells | Q40378902 | ||
| Expression of the functional soluble form of human fas ligand in activated lymphocytes. | Q40806057 | ||
| No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis | Q41075243 | ||
| Induction of apoptosis in mature T cells by tumour necrosis factor | Q41293478 | ||
| Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases | Q41321495 | ||
| Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 | ||
| Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. | Q41440696 | ||
| Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. | Q41440948 | ||
| A novel domain within the 55 kd TNF receptor signals cell death | Q41528172 | ||
| Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium | Q42808304 | ||
| Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing | Q42951871 | ||
| Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. | Q54177718 | ||
| Activation interferes with the APO-1 pathway in mature human T cells. | Q54239983 | ||
| Monoclonal antibody-mediated tumor regression by induction of apoptosis. | Q55059937 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones | Q70911120 | ||
| Fas ligand in human serum | Q71031959 | ||
| Fas-mediated apoptosis in primary cultured mouse hepatocytes | Q71660111 | ||
| Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver | Q71794021 | ||
| P304 | page(s) | 131-137 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Toxicology Letters | Q1796854 |
| P1476 | title | The CD95(APO-1/Fas)/CD95L system | |
| P478 | volume | 102-103 |
| Q36216032 | ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer |
| Q24536096 | Caspases: pharmacological manipulation of cell death |
| Q33717488 | Cell death induced by the Fas/Fas ligand pathway and its role in pathology |
| Q51371762 | Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes. |
| Q43717255 | Differential sensitivity of human papillomavirus type 16(+) and type 18(+) cervical carcinoma cells to CD95-mediated apoptosis |
| Q40643770 | Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis |
| Q43515221 | Drug resistance does not correlate with resistance to Fas-mediated apoptosis |
| Q51022799 | Dysfunctional spermatogenesis in transgenic mice overexpressing bHLH-Zip transcription factor, Spz1. |
| Q40484694 | Effects of Shenqi Fuzheng injection on Fas/FasL protein expression levels in the cardiomyocytes of a mouse model of viral myocarditis |
| Q33566824 | Enhancement of TRAIL-induced apoptosis by 5-fluorouracil requires activating Bax and p53 pathways in TRAIL-resistant lung cancers |
| Q21245465 | Main roads to melanoma |
| Q28368310 | Relatively low-dose cyclophosphamide is likely to induce apoptotic cell death in rat thymus through Fas/Fas ligand pathway |
| Q41114371 | Role of Programmed Cell Death in the Immunopathogenesis of Sepsis |
| Q34482821 | TRAIL/Apo-2L: mechanisms and clinical applications in cancer |
| Q82897837 | The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer |
| Q33864774 | The relevance of spontaneous- and chemically-induced alterations in testicular germ cell apoptosis to toxicology. |
Search more.